Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QN3Q
|
|||
| Former ID |
DIB009267
|
|||
| Drug Name |
LNA anti-miR-155
|
|||
| Synonyms |
LNA anti-miR-155 (cancer), Santaris Pharma; LNA anti-microRNA-155 (cancer), Santaris Pharma; LNA anti-miR-155 (Waldenstrom's macroglobulinemia/ chronic lymphocytic leukemia); LNA anti-miR-155 (Waldenstrom's macroglobulinemia/ chronic lymphocytic leukemia), Santaris Pharma; LNA anti-microRNA-155 (Waldenstrom's macroglobulinemia/ chronic lymphocytic leukemia), Santaris Pharma
Click to Show/Hide
|
|||
| Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Investigative | [1] | |
| Company |
Santaris Pharma A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.